Neurosense Therapeutics Ltd (NRSN NASDAQ) stock market data APIs
$0.9415
-0.05(-5.3%)
as of May 5, 2026
Try our APIs with
free plan!
Neurosense Therapeutics Ltd Financial Data Overview
Price chart is built with
Anychart
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Prev. Close
0.9415
Open
0.8936
High
0.9659
Low
0.888
52 wk Range
0.63-2.6
Market Cap
34 288 K
Shares Outstanding
36 100 K
EPS
0
Beta
1.58
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Neurosense Therapeutics Ltd data using free add-ons & libraries
Get Neurosense Therapeutics Ltd Fundamental Data
Neurosense Therapeutics Ltd Fundamental data includes:
- Net Revenue:
- EBITDA: -11 069 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Neurosense Therapeutics Ltd Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-25
- EPS/Forecast: -0.1058
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neurosense Therapeutics Ltd News
New
NeuroSense Therapeutics receives Nasdaq notices over listing requirements
* NeuroSense Therapeutics ( [https://www.neurosense-tx.com/]NRSN [https://seekingalpha.com/symbol/NRSN]) on Friday said that it had received notifications from the Nasdaq Stock Market that it was no...
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
Notifications have no immediate effect on the listing or trading of the Company's securities on Nasdaq Nasdaq has provided the Company until September 29, 2026 to regain compliance with both requirem...
NeuroSense Unveils Favourable Safety Analysis Data Of PrimeC In NST-AD-001 Study For Alzheimer's
(RTTNews) - NeuroSense Therapeutics Ltd. (NRSN), a clinical-stage biotechnology company developing treatments for severe neurodegenerative diseases, reported the completion of the safety analysis and ...
Sector Update: Health Care Stocks Retreat Late Afternoon
Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index falling 0.8% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Get Neurosense Therapeutics Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
